Phototoxicity Test of Dapsone Gel in Healthy Volunteers | NCT02108483 | Trialant
CompletedInterventionalPhase 1Updated Oct 9, 2018
Phototoxicity Test of Dapsone Gel in Healthy Volunteers
ClinicalTrials.gov ID
NCT02108483
Lead Sponsor
Almirall, S.A.INDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Phase 1
Enrollment
33Actual
Last Update Posted
Oct 9, 2018Actual
Start Date
Apr 2014
Primary Completion Date
May 2014Actual
Completion Date
May 2014Actual
Brief Summary
This study will evaluate the potential of dapsone gel and its vehicle to cause a phototoxic reaction following irradiation of the skin under controlled conditions.
Healthy Volunteers
dapsone gel
dapsone gel vehicle
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
-Healthy adults.
Exclusion Criteria:
Skin diseases, excessive hair, tattoos, pigmentation, scars or moles that could interfere with patch application